DNTH Dianthus Therapeutics, Inc.
$80.97▼ -2.09%
Healthcare
Other
Volume 161.1K
Avg Volume (10D) 970.2K
Key Metrics & Fundamentals
Market Cap
$4.53B
P/E Ratio
–
Div Yield
0.00%
52W Range
32.28 - 117.88
% vs 50 MA
-11.36%
% vs 200 MA
-2.53%
RSI-14
47.5
MACD Histogram
+1.4300
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$49.16M
Gross Rev
$761,000
Gross Profit
$761,000
EBITDA
-$61.47M
COGS
–
Operating Exp
$62.24M
Operating Income
-$61.48M
EBIT
-$61.48M
Pretax Income
-$50.22M
Net Income
-$50.22M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
Regeneron (REGN) Q3 Earnings and Revenues Beat Estimates
Zacks · Oct 30, 2026 6:40 AM ET
Halozyme Therapeutics (HALO) Reports Next Week: Wall Street Expects Earnings Growth
Zacks · Oct 29, 2026 9:00 AM ET
Roth Capital Initiates Coverage on Dianthus Therapeutics With Buy Rating
MT Newswires · Oct 27, 2026 7:26 AM ET
Dianthus Therapeutics (DNTH) Stock May Be Above Fair Value Following Its 5x Run
Simply Wall St. · Oct 20, 2026 5:15 AM ET
Dianthus Therapeutics Named to Fortune’s 2026 Best Workplaces in BioPharma List Amid Company Expansion
InvestorsHub · Oct 13, 2026 9:52 AM ET
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
GlobeNewswire · Oct 13, 2026 8:45 AM ET
Top Bank Names 6 Stocks With Major Catalysts Ahead
GuruFocus.com · Oct 2, 2026 12:16 PM ET
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 1, 2026 5:00 PM ET
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
GlobeNewswire · Sep 29, 2026 8:00 AM ET
Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering?
Simply Wall St. · Sep 24, 2026 4:10 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See DNTH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.